Fibrinolysis and Proteolysis » Fibrinolytic Factors and Inhibitors

Abstract Number: VPB0636

A Comparative Study Of Intravenous Bolus Versus Bolus With Continuous Infusion Of Tranexamic Acid To Reduce Blood Loss In Major Surgical Procedures

N. NEERU¹, V. ABRAHAM²

Abstract Number: PB0632

Activity of some protease inhibitors in patients with arterial hypertension of high risk.

E. Shorikov¹, D. Shorikova¹, P. Shorikov², A. Esmaeil²

Abstract Number: VPB0633

Adipokines and insulin resistance in young individuals with various metabolic phenotypes

V. Chulkov¹, N. Vereina², E. Gavrilova², E. Lenets², E. Pankova², S. Martynov², S. Sinitsin²

Abstract Number: VPB0635

Attenuation of Thrombotic Biomarkers in a Hyperlipidaemic Sprague Dawley Rats Model

I. KWAIFA¹, K. Perumal², H. Bahari³, K. Yong³, Z. Eshak⁴, S. Balan⁵, A. Abidin⁵, F. Ghadi³, L. Kong³, S. NOOR³

Abstract Number: OC 76.4

CM-352 reduces rivaroxaban-associated ICH by mechanisms dependent on MMP-10 and fibrinolysis inhibition

M. Navarro-Oviedo¹, J. Marta-Enguita¹, C. Roncal², J. Rodriguez², B. Zandio³, R. Lecumberri⁴, F. Machado¹, J. Oyarzabal¹, A. Pineda-Lucena¹, J. Páramo⁴, R. Muñoz³, J. Orbe⁵

Abstract Number: VPB0637

Comparison between Intermittent Bolus versus Continuous Intravenous Infusion of Tranexamic Acid in Hematological Disorders with Thrombocytopenia (BRAVE Trial)

B. Poojitha¹, J. John², A. Philips², k. Modak², P. DS²

Abstract Number: PB0630

Early Systemic Administration of a Natural Carboxypeptidase Inhibitor Potentiates tPA-mediated Thrombolysis: Evidence from Real-time Intravital Imaging Analysis of Microthrombi in Mice

N. Mathews¹, Y. Suzuki², N. Honkura², H. Sano², T. Urano²

Abstract Number: VPB0638

Effects of Clot Contraction on Clot Degradation: A Mathematical and Experimental Approach

R. Risman¹, A. Abdelhamid², J. Weisel³, B. Bannish⁴, V. Tutwiler²

Abstract Number: PB0627

Hypofibrinolysis in patients with aortic stenosis is driven by overexpression of plasminogen activator inhibitor type 1 (PAI- 1) associated with elevated oxidized lipoproteins

M. Kopytek¹, A. Undas², M. Ząbczyk², J. Natorska²

Abstract Number: PB0625

Influence of centrifugation and residual platelet count on PAI-1 plasma level, euglobulin clot lysis time and global fibrinolytic capacity of plasma

M. Bareille¹, T. LECOMPTE², F. Mullier³

Abstract Number: OC 76.3

Molecular Basis for the Conformational Selectivity of Thrombomodulin for TAFI or Protein C

M. Boffa¹, J. Ackersviller², H. Marier², R. Moric², H. Khan²

Abstract Number: PB0626

Plasminogen deficiency: a case series of an ultra-rare disease in a Spanish centre

O. Benítez Hidalgo¹, M. Huguet Mas², A. de Jaureguizar Tesas², M. Martínez García¹

Abstract Number: VPB0639

Strong Fibrinolysis with New Fermented Foods (Mung Bean Natto and Natto Miso)

H. Sumi¹, S. Naito¹, C. Yatagai¹, T. Mitsuo²

Abstract Number: PB0628

The characterization of clot-fibrinolysis waveform analysis and the investigation of usefulness in critical care patients with enhanced or suppressed fibrinolysis

O. Kumano¹, T. Tsuchida², M. Hayakawa²

Abstract Number: PB0629

The validation of new global fibrinolysis capacity assays in high tPA concentration situation and the comparison with thromboelastgraphy

O. Kumano¹, T. Tsuchida², M. Hayakawa²

Abstract Number: VPB0634

Veno-occlusive disease in pediatric patients after stem cell transplant is associated with impaired fibrinolysis

S. Hammer¹, V. Schneider², M. Döring², K. Althaus³, T. Backchoul⁴

Abstract Number: PB0631

VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow

G. Poolen¹, M. van Moorsel², C. Koekman¹, S. Verhoef¹, S. De Maat², A. Barendrecht², N. van Kleef¹, J. Meijers³, R. Schiffelers⁴, C. Maas², R. Urbanus⁵

Abstract Number: VPB0640

Vinegar Produce t-PA from Human Endothelial Cells

H. Sumi¹, T. Mitsuo², Y. Yanagisawa³, M. Imai¹